Skip to main content
Fig. 4 | BMC Pulmonary Medicine

Fig. 4

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Fig. 4

Network evidence map of SAEs. A total of 19 studies reported SAEs in the treatment of IPF with 13 drugs: 1 of Ambrisentan, 2 of Bosentan, 1 of GLPG1690, 1 of Imatinib, 1 of Macitentan, 1 of N-acetylcysteine, 5 of Nintedanib, 1 of Pamrevlumab, 2 of Pirfenidone, 1 of PRM-151, 1 of Sildenafil, 1 of Simtuzumab, 1 of Warfarin

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us